Stay updated on mFOLFIRINOX +/- Ramucirumab Clinical Trial
Sign up to get notified when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.

Latest updates to the mFOLFIRINOX +/- Ramucirumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check45 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check74 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.2%
- Check81 days agoChange DetectedThe website has updated its results reporting dates, with the first results expected to be posted on January 1, 2025, and has added detailed definitions for Progression Free Survival (PFS) and Overall Survival (OS), while removing previous entries related to unknown statuses and median overall survival assessments.SummaryDifference15%
Stay in the know with updates to mFOLFIRINOX +/- Ramucirumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.